20/12.5 Logo 5034
Pill imprint 20/12.5 Logo 5034 has been identified as Hydrochlorothiazide and lisinopril 12.5 mg / 20 mg.
Hydrochlorothiazide/lisinopril is used in the treatment of high blood pressure; heart failure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Hydrochlorothiazide/lisinopril 12.5 mg / 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydrochlorothiazide and lisinopril Images
- Imprint:
-
20/12.5
Logo 5034 - Strength:
- 12.5 mg / 20 mg
- Color:
- Yellow
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00172-5034
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
magnesium stearate
mannitol
corn starch
magnesium silicate
ferric oxide red
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67544-0418 | Prepak Systems Inc (repackager) |
| 23490-5821 | Palmetto State Pharmaceuticals Inc (repackager) |
| 43063-0065 | PDRX Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Hydrochlorothiazide and Lisinopril resources
- Lisinopril/Hydrochlorothiazide (Wolters Kluwer)
- hydrochlorothiazide and lisinopril (Cerner Multum)
- lisinopril and hydrochlorothiazide (Micromedex) - Includes Dosage Information
- Lisinopril and Hydrochlorothiazide (FDA)
- Lisinopril/Hydrochlorothiazide (Wolters Kluwer)
Search Again
